Surface modification of lipid–polymer hybrid nanoparticles with the combined PEG and heparin was developed to achieve a significant prolongation in blood circulation.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: